CHU d'Estaing

The trials here

What the 11 trials at this site are about, from their registry records.

Conditions

• Childhood cancers3 trials
• Colorectal cancer3 trials
• Neuroblastoma2 trials
• Chronic myeloid leukaemia1 trial
• Epilepsy1 trial
• Gastric and oesophageal cancer1 trial
• Myeloproliferative neoplasms1 trial
• Neuroendocrine tumours1 trial
• Pancreatic cancer1 trial
• Sarcoma1 trial

Phase

• Phase 25 trials
• Phase 1/22 trials
• Phase 32 trials
• Phase 2/31 trial

Status

• Recruiting5 trials
• Active, not recruiting4 trials
• Completed2 trials

Lead sponsor

• Fondation Franc.Cancerologie Digestive2 trials
• Centre Georges Francois Leclerc1 trial
• Centre Hospitalier Regional Et Universitaire De Brest1 trial
• Centre Hospitalier Universitaire Dijon1 trial
• Centre Leon Berard1 trial
• and 5 more

Running trials

• Recruiting

  Apixaban/rivaroxaban Versus Aspirin for primary prevention of thrombo-embolic complications in JAK2V617F-positive myeloproliferative neoplasms

  2024-515362-13-00· Phase 2/3· Centre Hospitalier Regional Et Universitaire De Brest· Source

• Active, not recruiting

  Treatment of microstellite stable metastatic colorectal cancer presenting high immune infiltrate with chemotherapy (XELOX or FOLFOX Bevacizumab) and immunotherapy ( Pembrolizumab)

  NCT04262687· Phase 2· Fondation Franc.Cancerologie Digestive· Source

• Active, not recruiting

  Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer

  NCT05476796· Phase 2· UNICANCER· Source

• Active, not recruiting

  Evaluation of Efficacy of Trifluridine/Tipiracil Plus an Anti-IL-1α True Human Antibody Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine

  NCT05201352· Phase 1/2· Centre Georges Francois Leclerc· Source

• Recruiting

  FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

  NCT04625907· Phase 1/2· University of Birmingham· Source

• Recruiting

  Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary

  NCT04325425· Phase 2· Centre Hospitalier Universitaire Dijon· Source

• Active, not recruiting

  Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase

  NCT04070443· Phase 2· Centre Leon Berard· Source

• Recruiting

  High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

  NCT04221035· Phase 3· Gustave Roussy, Cancer Campus, Grand Paris· Source

• Active, not recruiting

  PRODIGE 34 - ADAGE: Randomised phase III study evaluating adjuvant chemotherapy after resection of stage III colon adenocarcinoma in patients aged 70 and older

  NCT02355379· Phase 2· Fondation Franc.Cancerologie Digestive· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers2 recruiting
• Gastric and oesophageal cancer1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Neuroblastoma1 recruiting
• Neuroendocrine tumours1 recruiting
• Pancreatic cancer1 recruiting
• Sarcoma1 recruiting

Closed trials

• Completed

  Evaluation by a Vineland II Scale of Long-term Development of Children With Pyridoxine Dependent Epilepsy

  NCT06054347· University Hospital, Angers· Source

• Completed

  Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

  NCT01868269· Phase 3· Institut Curie· Source